2025³â 08¿ù 08ÀÏ ±Ý¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > Àαⴺ½º

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
 
¸ðµÎ 92606°³ÀÇ ´º½º°¡ °Ë»öµÇ¾ú½À´Ï´Ù.



GS25 ¡®»ý°úÀÏ ½º¹«µð¡¯ ¿î¿µÁ¡ ±âÁØ Àüü ÆÇ¸Å·® 3À§

2030 ¼¼´ë°¡ °í°´ 69.5%
GS25°¡ ¾÷°è ÃÖÃÊ·Î ¼±º¸ÀÎ »ý°úÀÏ ½º¹«µð Àü¿ë ±â±â GS¸®Å×ÀÏÀÌ ¿î¿µÇÏ´Â ÆíÀÇÁ¡ GS25°¡ º»°ÝÀûÀÎ ¹«´õÀ§¸¦ ¸Â¾Æ ÃÖ±Ù 2ÁÖ°£(6/23~7/6) ‘»ý°úÀÏ ½º¹«µð’ ¿î¿µ Á¡Æ÷ 20¿© °÷À» ´ë»óÀ¸·Î ÆÇ¸Å µ¥ÀÌÅ͸¦ ºÐ¼®ÇÑ °á°ú »ý°úÀÏ ½º¹«µð°¡ ‘Ä«Æä25 ¾Æ¸Þ¸®Ä«³ë’, ‘ÄÅ ¾óÀ½’¿¡ À̾î Àüü ÆÇ¸Å·® 3À§(´ã¹è Á¦¿Ü)¿¡ µî±ØÇÑ °ÍÀ¸·Î ºÐ¼®µÆ´Ù. GS25´Â Áö³­ÇØ 12¿ù ÆíÀÇÁ¡ ¾÷°è ÃÖÃÊ·Î Á÷¿µÁ¡ ÇѰ÷À» ÅëÇØ Áï¼® »ý°úÀÏ ½º¹«µð¸¦ ¼±º¸¿´´Ù. ÃֽŠ¸Ô°Å¸® Æ®·»µå¸¦ ¼±Á¡ÇϰíÀÚ ÆíÀÇÁ¡ Ư¼º¿¡ ¸Â´Â Àü¿ë ±â±â ...

¡®±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡¡¯ ¸ðÁý¡¦ÀÏ±Þ 100¸¸¿ø

ÀâÄÚ¸®¾Æx¾Ë¹Ù¸óxǪ¶ó´ß º¹³¯ ÀÌ»ö¾Ë¹Ù
ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸ó(´ëÇ¥ÀÌ»ç À±ÇöÁØ)ÀÌ º¹³¯À» ¸Â¾Æ ġŲ Àü¹® ºê·£µå Ǫ¶ó´ß ġŲ°ú ÇÔ²² ÀÌ»ö ¾Ë¹Ù¸¦ ¸ðÁýÇÏ´Â À̺¥Æ®¸¦ ÁøÇàÇÑ´Ù°í 21ÀÏ ¹àÇû´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ³»´Þ 3ÀϱîÁö Ǫ¶ó´ß ġŲ°ú Çù¾÷ÇØ º¹³¯ ±â³ä ÀÌ»ö °ø°í¸¦ ³»°í ‘±ñdzġŲ »À ¹Ù¸¦ ¾Ë¹Ù¸ó’°ú ‘±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡’¸¦ ¸ðÁýÇÑ´Ù. À̹ø À̺¥Æ®´Â ¾Ë¹Ù¸óÀÌ ÁøÇà ÁßÀÎ ´ë±Ô¸ð ÇÁ·Î¸ð¼Ç ‘2025 ¿©¸§ ¾Ë¹Ù Æä½ºÅ¸(¿©¾ËÆä)’ÀÇ ÀÏȯÀÌ´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ¿©¸§Ã¶ ¹«´õÀ§¿Í ²ß²ßÇÑ ³¯¾¾·Î ÁöÃÄ ÀÖ´Â ±¸Á÷ÀÚµéÀ» À§ ...

Novotech Report: How In-Vivo CAR-T May Reshape Cell Therapy Econo...
SYDNEY -- With in-vivo CAR-T therapies gaining global momentum, a new whitepaper from Novotech, a leading global full-service clinical Contract Research Organization (CRO) and scientific advisory company, offers insight into this next frontier of immunotherapy. In-Vivo CAR Therapies - Global Research and Development Landscape (2025) report explores the accelerating innovation in in-vivo CAR-T (Chimeric Antigen Receptor) technologies and their potential to reshape treatment across oncology, autoi ...
2024 Á¦³×½Ã½º ½ºÄÚÆ¼½Ã ¿ÀÇ °³¸· (2024-07-12)
¸ñÆ÷ ¹è°æÀ¸·Î ÇÑ À̾߱â¿Í °ø¿¬ ±×¸®°í ÇÑ ³¢ ½Ä»ç (2023-10-06)
¡®KB ÀÔ¿ø¡¤¼ö¼ú Çϳª¸¸ ¹°¾îº¸´Â °£Æí°Ç°­º¸Ç衯 Ãâ½Ã (2024-07-14)
¡®¼± ³ÑÀº ÆÐ¹Ð¸®¡¯ ºÎºÎ »çÀÌ µ·µ¶ÇØÁö´Â ³²¾Æ°ø Åõ¾î? (2024-08-30)
»ï¼ºÀüÀÚ, °¶·°½Ã ¿öÄ¡6 Ŭ·¡½Ä PXG ¿¡µð¼Ç Ãâ½Ã (2023-10-23)
BCÄ«µå, ±ÝÀ¶±Ç ÃÖÃÊ GPT-4 ±â¹Ý AIÅõÀÚºñ¼­ ¼­ºñ½º (2023-08-07)
[°æÁ¦] ¼ÒµæÁÖµµ¼ºÀå ¿©°Ç°ú Á¤Ã¥È¿°ú Á¦°í ¹æ¾È (2017-07-04)
ÀÎõ°¡±¸´ÜÁö °¡±¸°ø´Ü, ´Ù¿ì´×¼ÒÆÄ ÇÒÀÎÇà»ç (2016-01-12)
±¹°¡À¯°øÀÚ À¯°¡Á· °ø°ø ÀÓ´ë¾ÆÆÄÆ® °ø±Þ (2021-05-10)
iM¹ðÅ©, ±¹À¯Àç»ê Ưº°´ëÃâ Ãâ½Ã (2024-06-16)
ÀºÁ¤ÇѰú, ⸳ 20ÁÖ³â ¸Â¾Æ °¡Á¤ÀÇ ´Þ ÇÒÀÎ Çà»ç (2024-04-17)
Mahindra & Mahindra Selects Kinaxis to Drive Supply Chain Ef... (2024-10-05)
FIFA announces multi-year agreement with Rock-it Cargo as Of... (2024-12-06)
Sourcefit Secures Strategic Investment from 9 Basil, NextGen... (2024-01-05)
ÇÑÈ­»ý¸í ¡®ÇÑÈ­»ý¸í ½Ã±×´Ïó ¾ÏÄ¡·áºñº¸Ç衯 Ãâ½Ã (2024-07-07)
Çö´ëÀÚµ¿Â÷, 2025 ±×·£Àú Ãâ½Ã (2024-06-07)
12°³¿ù ³» ¹Ù²Ù°í ½ÍÀº »ýȰ ½À°ü (2022-11-20)
Çѱ¹Áö¿ª³­¹æ°ø»ç, ȯ°æ¼öµµ »õºû¼ö¿ø Á¶¼º »ó»ý¹ßÀü Çù¾à (2024-07-24)
IDBS, BIX 2024¼­ ´º¸ð´Þ¸®Æ¼ À§ÇÑ µðÁöÅÐÇ÷§Æû ¼Ò°³ (2024-07-24)
¾ÆÀÌÆù6S¡¤6S Ç÷¯½º 3D ǮĿ¹ö °­È­À¯¸® ¡®½´ÆÛ±Û¶ó½º¡¯ Çʸ§ (2015-11-06)
Securities Commission of The Bahamas Opens Consultation Peri... (2023-04-27)
GS25, ¾ÆÀ̽ºµþ±âÅÁÈÄ·ç ´Üµ¶ Ãâ½Ã (2023-10-11)
õ¾È ¿Ü±¹ÀÎ ÀÌÁֹΠ¹× û³â°ú ÇÔ²²ÇÏ´Â ½Ä¹®È­ ÇÁ·ÎÁ§Æ® ÃßÁø (2024-07-26)
ÇÑÈ­½Ã½ºÅÛ, KF-21 AESA ·¹À̴٠ù ¾ç»ê µ¹ÀÔ (2024-06-26)
Morgan Stanley Private Equity Asia Completes the Sale of MSS... (2024-11-10)
       [ÀÌÀü][1]....[607][608][609][610][611][612][613][614][615]...[3705][´ÙÀ½]

°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ
 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..